T John Martin Selected Research

Humoral Hypercalcemia Of Malignancy

1/2022	Parathyroid hormone-related protein in breast cancer bone metastasis.
11/2019	Brief exposure to full length parathyroid hormone-related protein (PTHrP) causes persistent generation of cyclic AMP through an endocytosis-dependent mechanism.
6/2009	Structural basis for antibody discrimination between two hormones that recognize the parathyroid hormone receptor.
2/2002	Nuclear transport of parathyroid hormone (PTH)-related protein is dependent on microtubules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T John Martin Research Topics

Disease

17	Neoplasms (Cancer) 01/2024 - 02/2002
12	Bone Resorption 01/2022 - 11/2003
8	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2006
8	Osteoporosis 01/2018 - 09/2005
7	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
5	Bone Diseases (Bone Disease) 01/2016 - 12/2007
4	Humoral Hypercalcemia Of Malignancy 01/2022 - 02/2002
4	Osteosarcoma (Osteogenic Sarcoma) 04/2015 - 08/2008
4	Inflammation (Inflammations) 08/2014 - 07/2004
3	Metabolic Bone Diseases (Osteopenia) 10/2021 - 02/2004
3	Hypercalcemia (Milk Alkali Syndrome) 06/2012 - 05/2011
2	Carcinoma (Carcinomatosis) 01/2018 - 11/2003
2	Osteolysis 04/2006 - 11/2003
2	Experimental Arthritis 07/2004 - 10/2002
1	Carcinogenesis 01/2024
1	Leukemia 01/2022
1	Hypertrophy 04/2021
1	Infections 11/2014
1	Arthritis (Polyarthritis) 08/2014
1	Anemia 05/2011
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 05/2011
1	Insulin Resistance 07/2009
1	Disease Susceptibility (Diathesis) 10/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2006
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2006
1	Osteochondroma (Osteocartilaginous Exostosis) 04/2002
1	Chondrosarcoma 04/2002
1	Chondroma (Enchondroma) 04/2002

Drug/Important Bio-Agent (IBA)

21	Parathyroid Hormone-Related ProteinIBA 01/2024 - 02/2002
7	Parathyroid Hormone (Parathormone)IBA 01/2024 - 03/2004
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
4	Hormones (Hormone)IBA 01/2021 - 06/2010
4	OsteoprotegerinIBA 02/2007 - 10/2002
3	CytokinesIBA 08/2014 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 02/2004
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2014
2	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 10/2014 - 04/2002
2	Neutralizing AntibodiesIBA 06/2009 - 02/2007
1	OSM-LIF ReceptorsIBA 01/2024
1	FollistatinIBA 04/2021
1	A-factor (Streptomyces)IBA 01/2021
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	amino-terminal parathyroid hormoneIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	abaloparatideIBA 01/2018
1	Cyclic AMP (AMP, Cyclic)IBA 01/2018
1	Teriparatide (Parathar)FDA Link 01/2018
1	RetinoidsIBA 01/2016
1	RecQ HelicasesIBA 04/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2014
1	Complement System Proteins (Complement)IBA 10/2014
1	AntigensIBA 08/2014
1	Oncostatin MIBA 08/2014
1	Anabolic AgentsIBA 06/2014
1	Small Interfering RNA (siRNA)IBA 07/2013
1	Erythropoietin FDA Link 05/2011
1	MineralsIBA 05/2011
1	Pamidronate (Aredia)FDA LinkGeneric 05/2011
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 05/2011
1	Calcitriol (Calcijex)FDA LinkGeneric 05/2011
1	CalciumIBA 05/2011
1	Furosemide (Lasix)FDA LinkGeneric 05/2011
1	Progesterone FDA LinkGeneric 06/2010
1	LigandsIBA 01/2010
1	OsteocalcinIBA 07/2009
1	Glucose (Dextrose)FDA LinkGeneric 07/2009
1	Insulin (Novolin)FDA Link 07/2009
1	Chemotactic FactorsIBA 05/2009
1	Interleukin-23 (Interleukin 23)IBA 10/2008
1	RNA (Ribonucleic Acid)IBA 08/2008
1	Estrogens (Estrogen)FDA Link 09/2007
1	RANK LigandIBA 02/2007
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2007
1	Activating Transcription Factor 4IBA 12/2006
1	Dietary ProteinsIBA 12/2006
1	Estrogen ReceptorsIBA 02/2006
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2006
1	Zoledronic Acid (Zometa)FDA Link 07/2004
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2004
1	Diphosphonates (Bisphosphonates)IBA 11/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2003

Therapy/Procedure

10	Therapeutics 01/2018 - 12/2006
1	Intramuscular Injections 04/2021
1	Chemoprevention 06/2010
1	Fracture Fixation 01/2007